Michael Howard Jones
Directeur Général chez Cell Guidance Systems Ltd.
Profil
Michael Howard Jones is the founder and CEO of Cell Guidance Systems Ltd.
since 2013.
He is currently a Director at Transine Therapeutics Ltd.
since 2018.
Previously, he worked as the Chief Information Officer at Cigna Behavioral Health, Inc.
Postes actifs de Michael Howard Jones
| Sociétés | Poste | Début |
|---|---|---|
Cell Guidance Systems Ltd.
 Cell Guidance Systems Ltd. BiotechnologyHealth Technology Cell Guidance Systems Ltd. develops tools for stem cell treatments and medical research. Its products include microvesicles, cell culture media, PODS growth factors, matrigen softwell and SINEUP. The firm also offers karyotype analysis, custom medium production, NTA profiling service and PODS proteins services. The company was founded by Michael H. Jones in 2010 and is headquartered in Cambridge, the United Kingdom. | Directeur Général | 01/01/2013 |
Transine Therapeutics Ltd.
 Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Directeur/Membre du Conseil | 01/08/2018 |
Anciens postes connus de Michael Howard Jones
| Sociétés | Poste | Fin |
|---|---|---|
Cigna Behavioral Health, Inc.
 Cigna Behavioral Health, Inc. Managed Health CareHealth Services Cigna Behavioral Health, Inc. provides healthcare services and plans. It manages behavioral health care benefits and employee assistance programs (EAPs) for health plan members nationwide. The firm's services include disability management programs for employees on short and long-term disability and referral services such as financial and legal services, childcare and eldercare. The company was founded in 1974 and is headquartered in Eden Prairie, MN. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Cigna Behavioral Health, Inc.
Cigna Behavioral Health, Inc. Managed Health CareHealth Services Cigna Behavioral Health, Inc. provides healthcare services and plans. It manages behavioral health care benefits and employee assistance programs (EAPs) for health plan members nationwide. The firm's services include disability management programs for employees on short and long-term disability and referral services such as financial and legal services, childcare and eldercare. The company was founded in 1974 and is headquartered in Eden Prairie, MN. | Health Services |
Cell Guidance Systems Ltd.
Cell Guidance Systems Ltd. BiotechnologyHealth Technology Cell Guidance Systems Ltd. develops tools for stem cell treatments and medical research. Its products include microvesicles, cell culture media, PODS growth factors, matrigen softwell and SINEUP. The firm also offers karyotype analysis, custom medium production, NTA profiling service and PODS proteins services. The company was founded by Michael H. Jones in 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Transine Therapeutics Ltd.
Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Health Technology |
